

Oncology/Genetics
Cepheid is expanding its Oncology portfolio to deliver life-changing technology to physicians and their cancer patients globally. We also offer a rapid test that detects the genetic risk for thrombosis.
Products

Xpert® BCR-ABL Ultra
Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)